Product Information
GATIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Leading Pharma, LLC, priced at $8.8549 per ML under NDC 69315033102. Its NADAC has been published 39 times since Jan 7, 2026.
FDA first approved this application on Nov 3, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315033102
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
GATIFLOXACIN ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA213542FDA Approved
11/3/2021
TE Code
AT
On Market Since
10/6/2025
Pharmacological Classes
Price Statistics
The NADAC for GATIFLOXACIN 0.5% EYE DROPS has been published 39 times since Jan 7, 2026, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8549 per ML |
|---|---|
| All-time high | $10.2339 (Feb 11, 2026) |
| All-time low | $7.5043 (Jul 22, 2026) |
| 52-week high | $10.2339 |
| 52-week low | $7.5043 |
| Median price | $8.8549 |
| Average price | $8.9328 |
| Largest weekly change | +9.0% (Aug 19, 2026) |
| Weeks tracked | 39 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GATIFLOXACIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GATIFLOXACIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GATIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for GATIFLOXACIN 0.5% EYE DROPS, manufactured by Leading Pharma, LLC, is $8.8549 per ML (NDC 69315033102), effective Sep 30, 2026.
How has the price of GATIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for GATIFLOXACIN 0.5% EYE DROPS has declined 11.0%. It has been tracked across 39 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for GATIFLOXACIN 0.5% EYE DROPS?
Since Jan 7, 2026, the NADAC for GATIFLOXACIN 0.5% EYE DROPS has ranged from a low of $7.5043 (Jul 22, 2026) to a high of $10.2339 (Feb 11, 2026), with a median of $8.8549 per ML.
Are there cheaper alternatives to GATIFLOXACIN 0.5% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of GATIFLOXACIN 0.5% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GATIFLOXACIN 0.5% EYE DROPS?
GATIFLOXACIN 0.5% EYE DROPS (NDC 69315033102) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.